|
|
Blood, 15 January 2005, Vol. 105, No. 2, pp. 584-591.
Prepublished online as a Blood First Edition Paper on September 7, 2004; DOI 10.1182/blood-2004-07-2613.
 Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia
Lawrence J. Druhan,
Jing Ai,
Pam Massullo,
Tamila Kindwall-Keller,
Mark A. Ranalli, and
Belinda R. Avalos
From the Bone Marrow Transplant Program and the Division of Hematology/Oncology, The Ohio State University, Columbus, OH; the Molecular, Cellular, and Developmental Biology Program, The Ohio State University, Columbus, OH; and the Department of Hematology/Oncology, Children's Hospital, Columbus, OH.
Severe congenital neutropenia (SCN) is a rare disease diagnosed at or soon after birth, characterized by a myeloid maturation arrest in the bone marrow, ineffective neutrophil production, and recurrent infections. Most patients respond to treatment with granulocyte colony-stimulating factor (G-CSF), and the majority harbor mutations in the neutrophil elastase gene. In the subset of patients with SCN transforming to acute myeloid leukemia (AML), mutations that truncate the cytoplasmic tail of the G-CSF receptor (G-CSFR) have been detected. Here, we report a novel mutation in the extracellular portion of the G-CSFR within the WSXWS motif in a patient with SCN without AML who was refractory to G-CSF treatment. The mutation affected a single allele and introduced a premature stop codon that deletes the distal extracellular region and the entire transmembrane and cytoplasmic portions of the G-CSFR. Expression of the mutant receptor in either myeloid or lymphoid cells was shown to alter subcellular trafficking of the wild-type (WT) G-CSFR by constitutively heterodimerizing with it. WT/mutant G-CSFR heterodimers appeared to be retained in the endoplasmic reticulum and/or Golgi and accumulate intracellularly. These findings together with 2 previous case reports of extracellular mutations in the G-CSFR in patients with SCN unresponsive to G-CSF suggest a common mechanism underlying G-CSF refractoriness.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
G-CSF receptor mutations mix it up
- Marshall Horwitz
Blood 2005 105: 440.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
N. Berliner
Lessons from congenital neutropenia: 50 years of progress in understanding myelopoiesis
Blood,
June 15, 2008;
111(12):
5427 - 5432.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Ai, L. J. Druhan, M. G. Hunter, M. J. Loveland, and B. R. Avalos
LRG-accelerated differentiation defines unique G-CSFR signaling pathways downstream of PU.1 and C/EBP{epsilon} that modulate neutrophil activation
J. Leukoc. Biol.,
May 1, 2008;
83(5):
1277 - 1285.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. N. Hebert and M. Molinari
In and Out of the ER: Protein Folding, Quality Control, Degradation, and Related Human Diseases
Physiol Rev,
October 1, 2007;
87(4):
1377 - 1408.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. De La Luz Sierra, P. Gasperini, P. J. McCormick, J. Zhu, and G. Tosato
Transcription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cells
Blood,
October 1, 2007;
110(7):
2276 - 2285.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. H. Mermel, M. L. McLemore, F. Liu, S. Pereira, J. Woloszynek, C. A. Lowell, and D. C. Link
Src family kinases are important negative regulators of G-CSF-dependent granulopoiesis
Blood,
October 15, 2006;
108(8):
2562 - 2568.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
